House Approves NCI’s First $4 Billion Budget, $22.8 Billion For NIH In FY2002.
Foundation Honors Three In Oncology; Society Wins Software Grant From Microsoft.
Arthur James, Ohio Founder Of Research Institute, Dead.
Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.
Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.
Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research
